| Style | Citing Format |
|---|---|
| MLA | Fs Hosseini Fatemeh SADAT, Mr Mobinizadeh Mohammadreza REZA. "Towards Equity-Oriented Topic Selection in Health Technology Assessment for Orphan Drugs in Iran: A Commentary." Health Policy and Technology, vol. 14, no. 6, 2025, pp. -. |
| APA | Fs Hosseini Fatemeh SADAT, Mr Mobinizadeh Mohammadreza REZA (2025). Towards Equity-Oriented Topic Selection in Health Technology Assessment for Orphan Drugs in Iran: A Commentary. Health Policy and Technology, 14(6), -. |
| Chicago | Fs Hosseini Fatemeh SADAT, Mr Mobinizadeh Mohammadreza REZA. "Towards Equity-Oriented Topic Selection in Health Technology Assessment for Orphan Drugs in Iran: A Commentary." Health Policy and Technology 14, no. 6 (2025): -. |
| Harvard | Fs Hosseini Fatemeh SADAT, Mr Mobinizadeh Mohammadreza REZA (2025) 'Towards Equity-Oriented Topic Selection in Health Technology Assessment for Orphan Drugs in Iran: A Commentary', Health Policy and Technology, 14(6), pp. -. |
| Vancouver | Fs Hosseini Fatemeh SADAT, Mr Mobinizadeh Mohammadreza REZA. Towards Equity-Oriented Topic Selection in Health Technology Assessment for Orphan Drugs in Iran: A Commentary. Health Policy and Technology. 2025;14(6):-. |
| BibTex | @article{ author = {Fs Hosseini Fatemeh SADAT and Mr Mobinizadeh Mohammadreza REZA}, title = {Towards Equity-Oriented Topic Selection in Health Technology Assessment for Orphan Drugs in Iran: A Commentary}, journal = {Health Policy and Technology}, volume = {14}, number = {6}, pages = {-}, year = {2025} } |
| RIS | TY - JOUR AU - Fs Hosseini Fatemeh SADAT AU - Mr Mobinizadeh Mohammadreza REZA TI - Towards Equity-Oriented Topic Selection in Health Technology Assessment for Orphan Drugs in Iran: A Commentary JO - Health Policy and Technology VL - 14 IS - 6 SP - EP - PY - 2025 ER - |